ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
BASF Venture Capital has invested $13.5 million in Allylix, a biotechnology firm that makes renewable specialty chemicals for the flavor and fragrance industry. BASF says its investment will allow it to broaden its use of renewable raw materials and that Allylix fits with its efforts in the aroma, cosmetic chemicals, and nutrition markets. The funding was part of an $18.2 million financing round that also involved existing investors, including Tate & Lyle Ventures. Allylix will use the money to commercialize products in its pipeline, the first of these being epi-β-vetivone. Trademarked Epivone, the chemical is a terpene structurally related to a key component of vetiver oil, an essential oil with a rich, woody aroma.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter